About Deep 6 AI
Deep 6 AI is a company based in Pasadena (United States) founded in 2013 was acquired by Tempus in March 2025. Deep 6 AI has raised $54.79 million across 6 funding rounds from investors including Tempus, SXSW and Techstars. Deep 6 AI offers products and services including Precision Matching Software and Cohort Builder. Deep 6 AI operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Pasadena, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Deep 6 Ai Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Deep 6 AI
Deep 6 AI offers a comprehensive portfolio of products and services, including Precision Matching Software and Cohort Builder.
Software that matches patients to clinical trials using data analysis.
Tool for identifying eligible patients in clinical studies quickly.
People of Deep 6 AI
Unlock access to complete
Unlock access to complete
Funding Insights of Deep 6 AI
Deep 6 AI has successfully raised a total of $54.79M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $26.89 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Deep 6 AI
Deep 6 AI has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Tempus, SXSW and Techstars.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies
|
Locked | Locked | Locked | |
|
Early-stage tech startups are invested in by GSR Ventures.
|
Locked | Locked | Locked |
Investor details for Deep 6 AI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Deep 6 AI
Investment portfolio details for Deep 6 AI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Deep 6 AI
Detailed financials for Deep 6 AI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Deep 6 Ai Comparisons
Peer comparison for Deep 6 AI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Deep 6 AI
Deep 6 AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
Detailed competitors of Deep 6 AI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Deep 6 Ai
Complete news archive for Deep 6 AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deep 6 AI
Deep 6 AI was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Deep 6 AI is headquartered in Pasadena, United States. It is registered at Pasadena, California, United States.
Deep 6 AI is a funded company, having raised a total of $54.79M across 6 funding rounds to date.
Deep 6 AI was founded in 2013 in Pasadena, United States, within the health technology sector. Artificial intelligence solutions are developed to address clinical trial challenges. Unstructured data from electronic medical records is processed to identify eligible patients efficiently. Trial onboarding times and record analysis costs are reduced, while patient recruitment and outcomes are supported for hospitals and pharmaceutical companies operating in the U.S.
Deep 6 AI offers Precision Matching Software and Cohort Builder.
Deep 6 AI has 6 investors. Key investors include Tempus, SXSW, Techstars, Novo Holdings, and Point72 Ventures.